product summary
Loading...
company name :
Alomone Labs
product type :
protein
product name :
Cav1.3/CACNA1D Blocking Peptide
catalog :
BLP-CC005
more info or order :
citations: 1
Reference
Hisatsune C, Shimada T, Miyamoto A, Lee A, Yamagata K. Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca2+ Influx via L-Type Ca2+ Channels. J Neurosci. 2021;41:8134-8149 pubmed publisher
image
image 1 :
Alomone Labs BLP-CC005 image 1
Expression of CaV1.3 in rat DRG - Immunohistochemical staining of adult rat dorsal root ganglion (DRG) with Anti-CaV1.3 (CACNA1D) Antibody (#ACC-005). Staining appears in clusters of cells (green) but not in axons. Staining of neurofilament 200 demonstrates partial overlap with CaV1.3 in neuronal staining but not in axons (red).
product information
CAT :
BLP-CC005
SKU :
BLP-CC005
Product Name :
Cav1.3/CACNA1D Blocking Peptide
Group Type :
Blocking Peptide
Type :
Synthetic peptide
Product Type :
BLP
Accession :
P27732
Applications :
WB IHC
Formulation :
Lyophilized Powder.
Peptide confirmation :
Confirmed by amino acid analysis and mass spectrometry
Storage After Reconstitution :
-20°C.
Storage Before Reconstitution :
Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C
Shipping and storage :
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Sequence :
(C)DNKVTIDDYQEEAEDKD, corresponding to amino acid residues 859-875 of rat CaV1.3
Applications may also work in :
WB IHC
Supplier :
Alomone Labs
Target :
CACNA1D
Long Description :
Cav1.3/CACNA1D Blocking Peptide (#BLP-CC005) is the original antigen used for immunization during Anti-CaV1.3 (CACNA1D) Antibody (#ACC-005) generation. The blocking peptide binds and 'blocks' Anti-Cav1.3/CACNA1D primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
Short Description :
A Blocking Peptide for Anti-Cav1.3/CACNA1D Antibody
Lead Time :
1-2 Business Days
Country of origin :
Israel/IL
Applications key :
CBE- Cell-based ELISA, FC- Flow cytometry, ICC- Immunocytochemistry, IE- Indirect ELISA, IF- Immunofluorescence, IFC- Indirect flow cytometry, IHC- Immunohistochemistry, IP- Immunoprecipitation, LCI- Live cell imaging, N- Neutralization, WB- Western blot
Form :
Lyophilized powder
Comment :
Contact Alomone Labs for technical support and product customization
Is Toxin :
No
UNSPSC :
41105329
Standard quality control of each lot :
Western blot analysis.
Reconstitution :
100 µl double distilled water (DDW)
Purity :
>70%
Concentration after reconstitution :
0.4 mg/ml.
Product page antibodies part of immunoge ... :
(C)DNKVTIDDYQEEAEDKD, corresponding to amino acid residues 859-875 of rat CaV1.3
Antigen preadsorption control :
1 µg peptide per 1 µg antibody
more info or order :
company information
Alomone Labs
Jerusalem BioPark (JBP), Hadassah Ein Kerem
P.O. Box 4287
Jerusalem 9104201
info@alomone.com
http://www.alomone.com
972 2 531 8002
headquarters: Israel